Time

Program

Speaker

10:00-10:10

Registration

10:10-10:20

Welcome and Congratulatory Remarks

Duck-Joo Lee

Chairman

(Council for Advanced Regenerative Medicine)

Hyung-woo Ko

Director General for Advanced Medical Support

(Ministry of Health and Welfare)

Moderator : Kyoung-hwan Roh, Executive Director (HLB BioCode)

[Session 1] Evaluation and Analytical Technology Development for Advanced Biopharmaceuticals

Chairperson

Sung-yong Won

Director of Research Institute

(GC Cell)

10:20-10:50

Advanced challenges and opportunities for the systemic humanized animal model in the present and near future

Mi-young Choi

CEO

(C&SR)

10:50-11:20

Organoid-Based Evaluation Technology in Advanced Biopharmaceutical R&D

Jae-young Yoo

Division Director

(Gradiant Bioconvergence)

11:20-11:50

Holotomography and artificial intelligence: label-free 3D imaging, classification, and inference of live cells, tissues, and organoids

Yong-keun Park

Chief Executive Officer

(Tomocube)

11:50-13:20

Lunch Time

[Session 2] 100 Days Until the Implementation of the Revised Advanced Regenerative Bio Act : What Should We Prepare?

Chairperson

Chae-ok Yoon

Chair of the CARM Policy Committee

(GeneMedicine)

13:20-13:40

Keynote Presentation

Mi-Hyun Jung

Executive Director

(CTX)

13:40-15:00

Panel Discussion

Mi-Hyun Jung

Executive Director

(CTX)

Soon-kil Jung

Director

(Division of Regenerative Medicine Policy, Ministry of Health and Welfare)

Min-young Kim

Professor

(CHA Bundang Medical Center)

Yeon-sil Yu

Director

(Kangstem Biotech)

Ju-hyuk Lee

President

(Pediatric Rare Incurable Eye Disease Association)

15:00-15:20

Coffee Break

[Session 3] Current Status of Induced Pluripotent Stem Cell (iPSC) Therapy Development

Chairperson

Yu-kyeong Hwang

President (CTX)

15:20-15:50

Development of iPSC Culture Media Using Customized Cell Media Platform Technology

Joo-youn Lee

Head of R&D center, Director

(Xcell Therapeutics)

15:50-16:20

Case Studies in iPSC-Based Cell Therapy Development

Sae-bom Lee

Senior Researcher

(CTX)

16:20-16:50

Considerations for Commercial Production of iPSCs

Ji-hyeon Ju

CEO

(YiPSCELL)

16:50-17:00

Closing